Clinical Trial Results: Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating allogeneic mesenchymal stem cell infusion therapy for endothelial dysfunction in diabetic patients with symptomatic ischemic heart …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Ischemic Heart Disease

Drugs mentioned

• Allogeneic mesenchymal stem cell infusion therapy

Snippet

Sponsor: Joshua M Hare | Conditions: Diabetes Mellitus, Ischemic Heart Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-06-16